Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 693-705
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.693
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.693
Figure 5 Cryptotanshinone suppresses the expression of Src homology 2 domain–containing phosphatase 2 (SHP2) and the cytotoxin-associated gene A-induced phosphorylation of SHP2.
A: AGS cells were transfected with pSR-HA-cytotoxin-associated gene A (CagA) or empty vector plasmid for 24 h and then treated with the indicated doses of cryptotanshinone (CTS) for 24 h; B: AGS cells were treated with the indicated doses of CTS for 24 h. Western blotting was performed to detect the expression of Src homology 2 domain–containing phosphatase 2 (SHP2) and phosphorylated SHP2. β-actin was used as a loading control.
- Citation: Chen ZM, Hu J, Xu YM, He W, Meng L, Huang T, Ying SC, Jiang Z, Xu AM. Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions. World J Gastrointest Oncol 2021; 13(7): 693-705
- URL: https://www.wjgnet.com/1948-5204/full/v13/i7/693.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i7.693